See what makes us different.

We develop disruptive AI technologies for
health and safety in workplaces and healthcare.

At our core, we are an artificial intelligence company developing disruptive tools for impairment testing and healthcare. We are developing AI based screening for the healthcare and workplace industries.

The recent advent of the COVID-19 pandemic has placed unprecedented stress on the global economy and highlights the need for tools to help screen mass populations for infectious diseases, with the hope of preventing pandemics in the future. In turn, we have expanded our proprietary AI technology to screen for infectious diseases such as COVID-19.

Additionally, psychiatric disorders such as depression, dementia and Alzheimer’s disease can carry a significant burden and early identification is the key to better management. To help address this, we are also expanding our proprietary AI technology to screen for psychiatric and/or brain disorders such as depression, dementia and Alzheimer’s disease. 

In addition to our Infectious Disease, Impairment, and Mental Disorders Screening tools, we have also acquired a TeleHealth Remote Patient Monitoring Platform that has been successful at many hospitals and trials.

Our Strategic Partnerships


Top 15 global IT companies as ranked by Forbes. $4.9B company owned by Mahindra Group (part of a $420.7B federation of companies).



One of Canada’s best-known institutions of higher learning and a leading university in the world.



One of India’s leading providers of comprehensive healthcare services with a network of 14 hospitals and 2,300+ leading


The Mahatma Gandhi Mission (MGM) New Bombay Hospital Vashi is one of the most advanced multi-specialty tertiary care centers in the heart of Navi Mubai in India.




Full-service expert in fabrication and management of exhibitions, events and experiences for leading brands with operations across North America.



Top ranked engineering school globally. Alumni: CEOs & CTOs working at many Fortune 500 companies including Google, IBM, and Microsoft.


India’s most progressive Tier 2 defence engineering company targeting the government and the public sector markets in
South Asia.


Our Products + Services


Our Rapid Mass Screening technology uses multispectral cameras and sensors to capture data patterns that are instantly analyzed by our AI models.
Our Remote Care Platform integrates wearables and Bluetooth devices that bring data together with compassionate care tools for specific applications.



Our screening solutions are powered by AI. We use multispectral cameras and sensors that capture data patterns that are instantly analyzed by our proprietary AI. Our AI models continuously evolve via Machine Learning to keep you safe. That is the power of AI.


Our Cannabis & Alcohol Screening technology tests for impairment using multispectral recognition technologies that capture data analyzed by our proprietary AI.


Mental illness is difficult to detect at early stages. Primarily due to a lack of diagnostic tools other than standardized surveys and subjective assessment from trained healthcare practitioners.

Using multispectral image patterns, we will be able to effectively determine signs of mental illnesses, including depression, dementia, and Alzheimer’s.


Our Remote Patient Monitoring & Telehealth platform for Long Term Care and Retirement Residences, Clinical Research Organizations, and Large Scale Employers.

Meet The Team

Prabhakar Srivastava

Dr. Deepu Banjeri

Dr. Dawn Decunha

Rakesh Malhotra

Dr. Navdeep Singh Nanda

Dr. Indranil Saha

Dr. Nitin Kadam

Kiran Kkumari

Dr. Tally Bodenstein

“My team and I are looking forward to working with Predictmedix team. Predictmedix is one of the young and leading AI companies which aims to improve our healthcare system through innovative and cutting-edge digital health technologies.”

Dr. Samira Rahimi

McGill University Department of Family Medicine

“The most interesting part is that Predictmedix focuses on AI solutions to problems that matter to all of us”

Kapil Raval

Advisor at Predictmedix. Director of Artificial Intelligence Business Development, Microsoft

In the News

Predictmedix Corporate Update

Toronto, ON / February 16, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to provide a corporate update on its recent activities. This update highlights the company’s recent product deployments in partnership with...